SPHK1 and ovarian carcinoma: In order to further determine whether SphK was involved in ovarian cancer angiogenesis, we examined the effects of SphK inhibition by SKI-II, a highly SphK selective inhibitor, on the angiogenic potential of ovarian cancer cells through using endothelial cell migration, invasion and tube formation assays.